Deignan Charles A.

Average Profitability
20.35%
Insider Buys Quantity
4
Insider Buys Sum
$35,110.00
Insider Sells Quantity
7
Insider Sells Sum
$115,017.99

Insider Activity of Deignan Charles A.

According to the SEC Form 4 filings, Deignan Charles A., being in a position of

  1. Chief Financial Officer at Clearside Biomedical, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 12900 shares for $16,512,
    over all time since 2016-06-07, has bought 19000 shares for $35,110, and sold 56497 shares for $115,018.

The largest purchase of all time was on 2019-03-15 and amounted to 10000 shares of Clearside Biomedical, Inc. for $13,600.

The largest sale of all time was on 2020-06-01 and amounted to 14992 shares of Clearside Biomedical, Inc. for $28,185.

Biography of Deignan Charles A.

No biography is available at this moment.

2024-01-19SaleClearside Biomedical, Inc.
CLSD
Chief Financial Officer
12,900
0.0207%
$1.28$16,5120%
2023-01-19SaleClearside Biomedical, Inc.
CLSD
Chief Financial Officer
14,030
0.0238%
$1.50$21,045-27.21%
2022-01-19SaleClearside Biomedical, Inc.
CLSD
Chief Financial Officer
8,833
0.0146%
$2.09$18,461-30.33%
2021-09-21SaleClearside Biomedical, Inc.
CLSD
Chief Financial Officer
2,800
0.0046%
$6.41$17,948-72.35%
2021-06-21SaleClearside Biomedical, Inc.
CLSD
Chief Financial Officer
2,938
0.0049%
$4.37$12,839-35.48%
2020-06-01SaleClearside Biomedical, Inc.
CLSD
Chief Financial Officer
14,992
0.0337%
$1.88$28,185+8.65%
2019-11-12PurchaseClearside Biomedical, Inc.
CLSD
Chief Financial Officer
7,500
0.0202%
$1.14$8,550+65.77%
2019-03-15PurchaseClearside Biomedical, Inc.
CLSD
Chief Financial Officer
10,000
0.0281%
$1.36$13,600-14.79%
2018-03-23PurchaseClearside Biomedical, Inc.
CLSD
Chief Financial Officer
500
0.0019%
$11.79$5,895-46.77%
2017-08-14PurchaseClearside Biomedical, Inc.
CLSD
Chief Financial Officer
1,000
0.0039%
$7.07$7,065+10.07%
2016-06-07SaleClearside Biomedical, Inc.
CLSD
Chief Financial Officer
4
<0.0001%
$7.00$28+13.15%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.